BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 7402798)

  • 21. [Adaptation of the oral dosage of theophylline to the asthmatic child. Value of a kinetic test by the intravenous route].
    Albertini M; Lapalus P; Maurin S; Boutte P; Mariani R
    Arch Fr Pediatr; 1982 Nov; 39(9):671-5. PubMed ID: 7165461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioavailability of sustained-release theophylline granules in apple sauce in pediatric asthmatic patients.
    Lotner GZ; Vanderpool GE; Carroll S; Tinkelman DG; Spangler DL
    Ann Allergy; 1983 Jan; 50(1):27-9. PubMed ID: 6849516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levels.
    van der Vet AP; Drost RH; Kreukniet J; Maes RA
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):423-9. PubMed ID: 6490224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Are theophylline determinations useful to the clinician during treatment with a sustained-release form of theophylline?].
    Autret E; Lebranchu Y; Blanchard P; Nsabiyumua F; Breteau M; Grenier B; Jonville AP
    Therapie; 1990; 45(1):19-22. PubMed ID: 2343431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A sustained release theophylline preparation: efficacy in childhood asthma with low serum theophylline levels.
    Rachelefsky GS; Katz RM; Siegel SC
    Ann Allergy; 1978 Apr; 40(4):252-7. PubMed ID: 345889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of significant arrhythmogenicity from chronic theophylline and beta-2-adrenergic combination therapy in asthmatic subjects.
    Kelly HW; Menendez R; Voyles W
    Ann Allergy; 1985 May; 54(5):405-10. PubMed ID: 2859818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of low-dose troleandomycin on theophylline clearance: implications for therapeutic drug monitoring.
    Kamada AK; Hill MR; Brenner AM; Szefler SJ
    Pharmacotherapy; 1992; 12(2):98-102. PubMed ID: 1570234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
    González MA; Straughan AB
    Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of serum concentrations of once and twice daily administration of ultra-retard theophylline in school children with bronchial asthma].
    Liebke C; Niggemann B; Wahn U
    Pneumologie; 1996 Nov; 50(11):752-5. PubMed ID: 9082442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of long-term oral administration of a sustained release theophylline preparation in children with chronic asthma.
    Cantani A; Businco E; Businco L; Solano A; Calabretta C
    Allergol Immunopathol (Madr); 1983; 11(1):11-4. PubMed ID: 6858803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid and sustained oral theophylline loading. An alternative to intravenous aminophylline therapy.
    Brown DL; Maddux MS; Organek HW; Bauman JL
    Arch Intern Med; 1983 Apr; 143(4):794-6. PubMed ID: 6838301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical effectiveness of a new preparation of sustained-release theophylline].
    Corrias A; Pelosi U; Corona GB; Burrai P; Corda R
    Pediatr Med Chir; 1989; 11(5):537-9. PubMed ID: 2631061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Continuous treatment of asthma in children with theophylline retard].
    de Blic J; Scheinmann P; Benoist MR; Ruff F; Paupe J
    Arch Fr Pediatr; 1983 Feb; 40(2):123-7. PubMed ID: 6870478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous use of rapidly absorbed and sustained release theophylline preparations in children.
    Hein EW; Domson JF; Sheen A; Buffone GJ; Sly RM
    Ann Allergy; 1979 Oct; 43(4):217-9. PubMed ID: 555597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Measurement of blood theophylline levels in the child: will this affect methods of prescription? (author's transl)].
    de Blic J; Scheinmann P; Menillet G; Santais MC; Ruff F; Paupe J
    Nouv Presse Med; 1979 Apr; 8(16):1311-4. PubMed ID: 482098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chronic asthma in children: comparison between a delayed-action theophylline preparation and a prompt-release aminophylline preparation].
    Longo G; Poli F; Strinati R; Longo F
    Pediatr Med Chir; 1984; 6(5):645-9. PubMed ID: 6535126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variations in theophylline concentrations detected by 24-hour saliva concentration profiles in ambulatory children with asthma.
    Tal A; Aviram M; Gorodischer R
    J Allergy Clin Immunol; 1990 Aug; 86(2):238-43. PubMed ID: 2384651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experience with theophylline for the management of chronic asthma.
    Weinberger M; Hendeles L
    Eur J Respir Dis Suppl; 1980; 109():120-33. PubMed ID: 6777183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of two dosage schedules of sustained release theophylline in pediatric patients.
    Loren ML; Kirsten EB
    Ann Allergy; 1980 Apr; 44(4):200-3. PubMed ID: 7369552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Theophylline serum levels unmodified by postprandial administration of a sustained-release preparation (Teonova).
    Cannizzaro GF; Pesce L; Zanoli P; Milani GF; Zannoni F; Pivirotto F
    Int J Clin Pharmacol Res; 1988; 8(1):37-41. PubMed ID: 3366501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.